• Rigel Announces New Appointment to Board of Directors americanpharmaceuticalreview
    August 28, 2017
    Rigel Pharmaceuticals announced that Brian L. Kotzin, M.D. has been appointed to Rigel's board of directors. Kotzin brings to Rigel's board three decades of experience in the areas of immunology and inflammation.
PharmaSources Customer Service